CEP27055: A Novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic Activity and antitumor efficacy in preclinical models - Ruggeri, B; Singh, J; Gingrich, D; Angeles, T; Albom, M; Yang, S; Chang, H; Robinson, C; Hunter, K; Dobrzanski, P; Jones-Bolin, S; Pritchard, S; Aimone, L; Klein-Szanto, A; Herbert, J M; Bono, F; Schaeffer, P; Casellas, P; Bourie, B; Pili, R; Isaacs, J; Ator, M; Hudkins, R; Vaught, J; Mallamo, J; Dionne, C (Cancer Res, 2003)